Weifang Yu
Overview
Explore the profile of Weifang Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han S, Jiang H, Wang J, Li C, Liu T, Xuan M, et al.
J Cancer
. 2025 Feb;
16(5):1420-1437.
PMID: 39991580
Wilms tumor 1 associated protein (WTAP) is a key RNA N6-methyladenosine (mA) methylase, which is involved in gastric cancer (GC) development, but its pathogenic mechanism is not clear. This study...
2.
Yang M, He X, Xu J, Yu W
J Chromatogr A
. 2024 Oct;
1736:465405.
PMID: 39378626
Analytical solution to ideal chromatography model has been established for binary Langmuir isotherm and rectangular injections. However, retention time of the less adsorbed species, which is of great theoretical and...
3.
Shi L, Wang X, Guo S, Gou H, Shang H, Jiang X, et al.
Oncogene
. 2024 Feb;
43(13):931-943.
PMID: 38341472
Copy number alterations are crucial for the development of gastric cancer (GC). Here, we identified Transmembrane Protein 65 (TMEM65) amplification by genomic hybridization microarray to profile copy-number variations in GC....
4.
Liu T, Zhai C, Tian B, Li C, Han S, Wang S, et al.
Sci Rep
. 2024 Jan;
14(1):2588.
PMID: 38297025
Roundabout guidance receptor 2 (Robo2) is closely related to malignant tumors such as pancreatic cancer and liver fibrosis, but there is no relevant research on the role of Robo2 in...
5.
Wang L, Liu T, Yue H, Zhang J, Sheng Q, Wu L, et al.
Front Cell Infect Microbiol
. 2023 Dec;
13:1294904.
PMID: 38145047
Objective: The Omicron variant has a weaker pathogenicity compared to the Delta variant but is highly transmissible and elderly critically ill patients account for the majority. This study has significant...
6.
Yu W, Wang J, Li C, Xuan M, Han S, Zhang Y, et al.
J Cancer
. 2022 Feb;
13(3):918-931.
PMID: 35154459
MicroRNA (miRNA) can affect tumor progression by regulating cell proliferation, apoptosis and metastasis. A significant upregulation of miR-17-5p expression was found in colorectal cancer (CRC) tissues by miRNA microarray chip...
7.
Jiang X, Wang J, Wang M, Xuan M, Han S, Li C, et al.
Cancer Med
. 2021 Aug;
10(19):6823-6834.
PMID: 34414684
Purpose: To develop new and effective biomarkers for the diagnosis of colorectal cancer (CRC). Experimental Design: The serum expression of ITGB4 (49 CRC and 367 HC) was detected by enzyme-linked...
8.
He X, Zhang L, Qiu H, Jiang X, Zhang F, Peng J, et al.
Eur J Vasc Endovasc Surg
. 2021 Jul;
62(4):622-628.
PMID: 34244092
Objective: Presently, the prone position is necessary for popliteal vein puncture access, but it makes the patients uncomfortable and does not allow traditional femoral or jugular access. To address these...
9.
Shang F, Jiang X, Wang H, Chen S, Wang X, Liu Y, et al.
J Gastrointest Oncol
. 2021 Jan;
11(6):1224-1232.
PMID: 33456995
Background: Colorectal cancer (CRC) is the most common gastrointestinal malignancy. And probiotics may have the function of preventing colon cancer. The aim of this study was to investigate the inhibitory...
10.
Liu Y, Wang G, Jiang X, Li W, Zhai C, Shang F, et al.
J Cancer
. 2020 Sep;
11(20):6025-6037.
PMID: 32922543
We recently reported that tripartite motif-containing 67 () activates p53 to suppress colorectal cancer (CRC). However, the function and mechanism of in the inhibition of CRC cell proliferation and metastasis...